Skip to content
AnalystLens

SynopsysSNPS

Legal name
Synopsys, Inc.
Sector
Technology
Industry
Services-Prepackaged Software
Exchange
Nasdaq

Stock Price $SNPS

Latest filings

You are here#39 of 88 in Technology by market cap

Filing record · 2016–202610-K1010-Q338-K142

SNPS filed 10 annual reports (10-K), 33 quarterly reports (10-Q) and 142 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’16Nov ’16
  2. Leadership change8-K · Apr ’19Apr ’19
  3. Leadership change8-K · Dec ’21Dec ’21
  4. FY2025 annual report10-K · Dec ’25Dec ’25

01—Key figures

Source: 10-KFY2025
Source: 10-KFY2025
Source: 10-KFY2025
Source: 10-KFY2025

Revenue Trend

Year-over-year comparison from 10-K annual reports

  18. $7.05B
YoY changeLargest recent move+15.2%in FY24Latest +15.1%

Latest bar from 10-KFY2025Click a bar to open its SEC filing

View full history →
All SNPS Financial Metrics63 metrics

Income Statement17

Balance Sheet28

Cash Flow14

Per Share4

02—Overview

Synopsys Financial Overview 2021–2025

Updated Nov 3, 2026

Driven by the monumental $35.0 billiona acquisition of engineering software giant Ansys, Synopsys posted a massive 66% revenue increase to $2.4 billion in Q1 2026. This transformative deal underscores the central investment thesis: Synopsys is aggressively evolving from a pure-play electronic design automation vendor into a comprehensive "silicon-to-systems" juggernaut, though at a steep near-term cost to profitability. The strategy builds on a foundation of consistent top-line expansion, as total annual revenue grew from $4.2 billion in FY2021 to $7.1 billion in FY2025.

While the Ansys integration contributed $756.6 million in revenueb during FY2025, the operational reality of absorbing a mega-merger has introduced intense financial friction. Spiking amortization and operating costs dragged Q1 2026 net income down to just $65.0 million—a sharp decline from $295.7 million a year prior. Management is simultaneously navigating severe headwinds in its Design IP segment, which suffered a 22% revenue decrease in China during FY2025 due to export control restrictions. To fund the cash portion of the merger, the company issued $10 billion in senior notes with interest rates up to 5.700%, significantly increasing its debt load and triggering a major workforce restructuring. Despite these integration hurdles and rising interest expenses, investors have priced in robust expectations; at the close of FY2025, Synopsys commanded an $84.4 billion market cap and traded at 56.4x earnings with a stock price of $453.82.

Recent Developments (Q2 and Q3 2026)

Synopsys beat guidance in both quarters and cut leverage. Q3 2026 revenue rose 42% to $2.477 billionc, and non-GAAP EPS reached $3.91. Q2 2026 GAAP EPS was only $0.09 after $115.9 million of restructuring charges, while Q3 GAAP EPS recovered to $2.84. Gross margin widened to 72.6% from 66.6%. Design IP returned to growth at $473.8 million. Long-term debt fell to $9.02 billion from $13.46 billion. Restructuring costs are now projected at $425–500 million. Elliott's Jesse Cohn joined the board on June 1, 2026. General Counsel Janet Lee is stepping down. A $1 billion accelerated share repurchase followed in October 2026.

Bull case: FY2026 guidance rose to $9.69–9.74 billiond in revenue, with $10.9 billion of backlog. Bear case: at 51.0x earnings as of the Q3 2026 report date (August 25, 2026), the stock is richly valued, and the repurchase implies roughly $576 per share, well above that $410.00 close.

What to watch: Investor Day on September 30, 2026 targets and Q4 2026 guidance of $2.53–2.58 billione in revenue; export control changes affecting Design IP

03—Filings

Recent SEC Filings

  1. 8-KSynopsys 8-K Report, Corporate Update (Oct 5, 2026)On October 5, 2026, Synopsys, Inc. (Nasdaq: SNPS) disclosed in a Form 8-K that it has entered into an accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank, National Association, to repurchase an aggregate of $1 billion of its common stock. The announcement was made via a press release furnished as Exhibit 99.1 and is filed under Item 8.01 (Other Events), indicating the company considers it a voluntary disclosure rather than a mandatory event such as a material definitive agreement. Under the ASR terms, Synopsys receives an initial share delivery of approximately 1,735,000 shares at inception. The final number of shares repurchased will be determined by the average of Synopsys' daily volume-weighted average share prices over the repurchase period, less an agreed discount. Any remaining shares are to be settled on or before January 5, 2027, upon completion of the repurchase period. At the initial delivery figure, the implied price is roughly $576 per share ($1 billion divided by 1.735 million shares), though the final count may rise or fall depending on realized prices. For investors, the transaction signals management's confidence in the company's valuation and its capital allocation priorities, as it returns $1 billion to shareholders through a mechanism that front-loads share retirement and reduces share count. The filing does not include updated financial guidance, earnings impact, or details on funding sources, so the broader financial effect (including any balance sheet or cash flow implications) should be evaluated against Synopsys' latest 10-Q and 10-K disclosures. Forward-looking risks noted include stock price movement during the repurchase period and JPMorgan's ability to buy or borrow shares.
  2. 8-KSynopsys 8-K/A Report, Exit or Disposal Costs (Aug 26, 2026)Synopsys Inc. (SNPS) has filed an 8-K detailing updated estimates for its previously disclosed Restructuring Plan. The company now anticipates recognizing pre-tax charges between $425 million and $500 million, an increase from prior estimates. These charges are primarily associated with severance and one-time termination benefits, along with costs related to global site closures as part of its strategic initiative. Investors should note that these updated figures reflect a range, and the actual charges could vary. The company explicitly states that these forward-looking statements are subject to risks and uncertainties, including the ability to successfully implement the restructuring across various jurisdictions, potential changes in the components and timing of costs, and the realization of anticipated benefits. Investors are advised to consult the "Risk Factors" section in Synopsys's latest SEC filings for a more comprehensive understanding of these potential risks.
  3. 8-KSynopsys 8-K Report, Financial Results (Aug 26, 2026)Synopsys (SNPS) reported third fiscal quarter 2026 results (quarter ended July 31, 2026) with revenue of $2.477 billion, up roughly 42% from $1.740 billion a year earlier, driven by the Ansys acquisition and strength in Design Automation. GAAP diluted EPS was $2.84 versus $1.50 a year ago, while non-GAAP diluted EPS was $3.91 versus $3.39. Management attributed the beat to broad-based strength led by EDA, a strong Ansys contribution, and a return to year-over-year growth in Design IP. Design Automation revenue rose to $2.003 billion (about 81% of total) with a 45.2% adjusted operating margin, while Design IP grew to $473.8 million, though its adjusted margin expanded to 26.5% from 20.1%. Management raised full-year fiscal 2026 guidance: revenue of $9.69–9.74 billion, non-GAAP EPS of $15.04–15.10, operating cash flow of about $2.8 billion, and free cash flow of about $2.6 billion. Fourth-quarter guidance calls for revenue of $2.53–2.58 billion and non-GAAP EPS of $4.10–4.16. Guidance assumes no further changes to export controls or the Entity List restrictions. Investors should note that GAAP results are heavily affected by large non-cash amortization of acquired intangibles ($402 million in the quarter) and that the company has changed its non-GAAP tax methodology to a normalized 18% rate. Balance sheet activity was significant: long-term debt fell to $9.02 billion from $13.46 billion at fiscal year-end 2025, short-term debt rose to $1.02 billion, and cash and short-term investments reached $3.61 billion. The company also cited a $2.0 billion common stock issuance for a private placement and $300 million of treasury stock repurchases during the nine months. Final third-quarter financials will be filed in the Form 10-Q on or before September 9, 2026.
  4. 8-KSynopsys 8-K Report, Executive Changes (Aug 12, 2026)Synopsys, Inc. (SNPS) has announced a significant leadership transition involving its General Counsel and Corporate Secretary, Janet Lee. Effective August 12, 2026, Ms. Lee will step down from her executive roles, with a definitive departure date set for either December 31, 2026, or upon the appointment of her successor, whichever comes first. This change is part of a planned transition to ensure continuity in legal and corporate governance matters. Following her departure from her executive duties, Ms. Lee will assume an advisory role until June 30, 2027, or a later date as agreed upon, to facilitate a seamless handover. This arrangement aims to leverage her expertise during the transition period while preparing for new leadership in these critical functions. Investors should monitor the company's progress in appointing a successor for Ms. Lee.
  5. 8-KSynopsys 8-K Report, Financial Results (May 27, 2026)Synopsys reported second-quarter fiscal 2026 results (quarter ended April 30, 2026) with revenue of $2.276 billion, up roughly 42% from $1.604 billion a year earlier, largely reflecting the Ansys acquisition. GAAP net income attributable to Synopsys fell sharply to $17.1 million, or $0.09 per diluted share, from $349.2 million ($2.24) a year ago, weighed down by $403.6 million of acquired-intangible amortization, $222.3 million of stock-based compensation, and $115.9 million of restructuring charges. On a non-GAAP basis, EPS was $3.35 versus $3.67 last year, with non-GAAP net income of $643.7 million. Revenue and non-GAAP EPS both exceeded company guidance. Management raised full-year fiscal 2026 revenue guidance to a midpoint of $9.665 billion (from $9.610 billion) and non-GAAP EPS guidance to a midpoint of $14.76 (range $14.72 to $14.80). The revenue raise combines $35 million of business performance and $60 million from an EPS-neutral Ansys channel accounting impact, partly offset by a $40 million reduction tied to the pending divestiture of the Processor IP Solutions business. Management also raised targets for operating margin, free cash flow (now about $2.0 billion), and operating cash flow (about $2.3 billion). Balance sheet activity was significant: long-term debt fell to $10.01 billion from $13.46 billion at October 31, 2025, following $3.46 billion of debt repayments in the first half, funded partly by a $2.0 billion private placement of common stock. Shares outstanding rose to 191.4 million from 186.0 million. Investors should note that the Design IP segment's adjusted operating margin contracted to 24.4% in the quarter from 31.2% a year earlier, and that the company plans an Investor Day on September 30, 2026 to outline long-term financial targets.
View all 8-K filings →
View all filings (10-K, 10-Q, 8-K, proxy & more) →

04—See also

Related Companies

Annual revenue over each company’s last eight fiscal years, each strip on its own scale from zero.